We also describe an unusually strong host immune response (compared with other GMM mammary cancer models, including GMM transplants such as the Met1 model Fig. 1a [22]) to the invasive Stat1-null neoplasm that increases with lesion progression. This evidence concerns the gene STAT1 and neoplasm.